Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway
Open Access
- 21 September 2010
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 9 (1), 253
- https://doi.org/10.1186/1476-4598-9-253
Abstract
Background: Trop2 is a cell-surface glycoprotein overexpressed by a variety of epithelial carcinomas with reported low to restricted expression in normal tissues. Expression of Trop2 has been associated with increased tumor aggressiveness, metastasis and decreased patient survival, but the signaling mechanisms mediated by Trop2 are still unknown. Here, we studied the effects murine Trop2 (mTrop2) exerted on tumor cellular functions and some of the signaling mechanisms activated by this oncogene. Results: mTrop2 expression significantly increased tumor cell proliferation at low serum concentration, migration, foci formation and anchorage-independent growth. These in vitro characteristics translated to increased tumor growth in both subcutaneous and orthotopic pancreatic cancer murine models and also led to increased liver metastasis. mTrop2 expression also increased the levels of phosphorylated ERK1/2 mediating cell cycle progression by increasing the levels of cyclin D1 and cyclin E as well as downregulating p27. The activation of ERK was also observed in human pancreatic ductal epithelial cells and colorectal adenocarcinoma cells overexpressing human Trop2. Conclusions: These findings demonstrate some of the pathogenic effects mediated by mTrop2 expression on cancer cells and the importance of targeting this cell surface glycoprotein. This study also provides the first indication of a molecular signaling pathway activated by Trop2 which has important implications for cancer cell growth and survival.Keywords
This publication has 48 references indexed in Scilit:
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Trop2: A possible therapeutic target for late stage epithelial carcinomasBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikisCell Death & Differentiation, 2009
- A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in CancerClinical Cancer Research, 2009
- Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristicsProceedings of the National Academy of Sciences of the United States of America, 2008
- High expression of TROP2 correlates with poor prognosis in pancreatic cancerBritish Journal of Cancer, 2008
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradationNature, 2008
- The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene, 2007
- Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancerCarcinogenesis: Integrative Cancer Research, 2003
- Involvement of intact inositol‐1,4,5‐trisphosphate‐sensitive Ca2+ stores in cell cycle progression at the G1/S boundary in serum‐stimulated human fibroblastsFEBS Letters, 1995